Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML
Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML
Not yet recruiting · NCT07643636 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 2 | 2026-06-18 | NCT07643636 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dongguan People's Hospital | 32 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||